Clinical Trial Update: Development of Novel Clinical Endpoints in Intermediate AMD

View source ↗

Summary

This clinical trial update discusses development and validation of novel clinical endpoints for intermediate age-related macular degeneration (AMD).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration

Snippet

Sponsor: Frank G. Holz | Conditions: Age Related Macular Degeneration (AMD) | Status: ACTIVE_NOT_RECRUITING